|
HS Code |
578827 |
| Name | Ponasterone A |
| Cas Number | 484-63-5 |
| Molecular Formula | C27H44O4 |
| Molecular Weight | 432.64 |
| Appearance | White to off-white powder |
| Solubility | Soluble in ethanol, DMSO, and methanol |
| Purity | ≥98% (HPLC) |
| Melting Point | 183-185°C |
| Storage | Store at -20°C, protected from light |
| Synonyms | Ponasteron A; Ecdysteroid; MD 301; 20-Hydroxyecdysone analog |
| Canonical Smiles | CC(CCC1(C2CCC3(C(C2(CCC1O)C)C(=O)CC4C3(CCC(C4(C)O)C)O)C)C)O |
| Usage | Ecdysone receptor agonist; used in gene expression studies |
| Source | Isolated from plants such as Podocarpus nakaii |
As an accredited Ponasterone A factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Ponasterone A is packaged in a 10 mg amber glass vial, sealed with a screw cap, and labeled with product details. |
| Shipping | Ponasterone A is shipped in compliance with chemical safety regulations. It is securely packaged in appropriate containers, often with cooling packs to maintain stability. Shipping is typically via express courier to ensure timely delivery, and all packages include safety documentation and labeling as per international transport guidelines for controlled laboratory reagents. |
| Storage | Ponasterone A should be stored at -20°C in a tightly sealed container, protected from light and moisture. The storage area should be well-ventilated and free from sources of ignition. Avoid repeated freeze-thaw cycles to maintain stability. Proper labeling and segregation from incompatible substances, such as oxidizers, are essential to ensure safety and chemical integrity during storage. |
Applications of Ponasterone A in Industrial ManufacturingAs a genuine producer of high-purity Ponasterone A, we deliver this critical ecdysteroid intermediate to established industrial sectors with tangible downstream integration. Below, we outline our main B2B application fields, detailing precise regulatory frameworks, formulation guidance, routes of incorporation, and finished product outputs based on verified production practices. 1. Insect Cell Culture for Recombinant Protein Expression (Baculovirus Systems)Ponasterone A serves as an inducer in the baculovirus expression vector system (BEVS), especially for regulated gene expression with chimeric promoters in insect cell lines such as Sf9 or High Five. Biotechnology firms utilize our material to activate transcription sequences in research and cGMP production of recombinant proteins, monoclonal antibodies, vaccine antigens, and viral vectors. The purity and lot-to-lot consistency of Ponasterone A are critical for reproducibility in bioprocess scale-up and downstream QC batch release. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Development and Optimization of Ecdysone-Inducible Mammalian Expression SystemsPharmaceutical technology and gene therapy companies apply Ponasterone A within tightly regulated mammalian expression platforms. By modulating target gene transcription in engineered cell lines (CHO, HEK293, etc.), Ponasterone A enables tunable, inducible gene expression for the controlled manufacture of advanced biologics and gene-editing payloads. Strict control of induction timing and concentration ensures compliance with regulatory standards for genetically modified bioproducts. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Structural and Functional Studies of Ecdysteroid Receptors in Academic and Pharmaceutical ResearchResearch institutions and contract research organizations (CROs) employ high-purity Ponasterone A in receptor-ligand interaction assays, cell-based reporter systems, and crystallization screens exploring ecdysteroid signaling. Accurate dosing and trace impurity control are especially important to ensure reliable data in preclinical pharmacology studies or structural biology investigations targeting receptor modulation. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Reference Standard Production for Analytical LaboratoriesCertified analytical and calibration laboratories require Ponasterone A as a primary or secondary reference standard for quantitation in biological, pharmaceutical, and environmental matrices. Our material, traceable to ISO reference material guidelines and delivered with a comprehensive certificate of analysis, enters the reference standard manufacturing workflow at the stage of batch preparation, dissolution, and aliquoting, supporting laboratories pursuing method validation or routine release testing. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Ponasterone A prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
As a team that spends each day deep in the process of making Ponasterone A, we find the conversation about this ecdysteroid shifts often between textbooks and real-life bench work. There’s a gap between what reference guides capture and what long hours in stainless reactors reveal. Ponasterone A, with the model identifier CAS 524-06-3, works as much in the hands of a synthetic chemist as it does in the research pipeline for insect studies and receptor assay screening. The molecule became a topic of heavy interest when the search grew for alternatives to muristerone and other ecdysteroids for receptor binding studies. We have spent years refining its production, wrestled with its purification, and debated its quirks in product meetings. The result is a compound that rarely makes headlines but consistently pushes scientific projects forward.
Ponasterone A carries the formula C27H44O4 and falls into a structural class that looks close to 20-hydroxyecdysone—another ecdysteroid that often gets more attention in bodybuilding chats than in the references that catalog actual bench protocols. Chemists recognize Ponasterone A for its four fused rings, the subtle detail being the positions of hydroxyl groups on the backbone. In its purified form, the powder runs white to off-white, stable under dry storage, and responds well to low-light handling. We guarantee a purity exceeding 98%, confirmed batch-to-batch by HPLC and NMR. These are not just pretty numbers—this level of consistency cuts down on batch-to-batch variation in research, a detail every biologist chasing statistical significance will appreciate.
Making Ponasterone A is never about dialing in a few easy parameters and running a batch. It means careful monitoring from fermentation to downstream purification. We’ve found the fermentation step—the natural route using plant or insect cell cultures—demands both experience and sound equipment. A minor slip-up in pH or timing can yield a spike in side-products. We’ve adopted robust monitoring systems, powdered by nearly a decade of repeatedly scaling up production batches. Beyond fermentation, the real challenge turns up in separating Ponasterone A from related ecdysteroids, which love to co-elute on chromatographic columns. Crystal form consistency depends on this high-level purification.
Industry talk sometimes circles around newer synthesis methods or wild batch claims. Our approach keeps quality at the center, and the lessons come from back-and-forth learning. Some labs target a quick-and-dirty approach; we target a crystalline solid with the right melting point and indistinguishable NMR spectra year-round. This iterative process is as much about human supervision as it is about machine control, a point often lost in the rush for automation.
It is tempting to stack Ponasterone A next to 20-hydroxyecdysone or muristerone A and call their functions similar. Our on-the-ground feedback from global research teams tells a different story. While similarities exist—they’re all ecdysteroids, after all—the biological potency of Ponasterone A in inducing gene expression via ecdysone receptors stands noticeably higher. In Drosophila and transgenic cell lines that rely on ecdysone-inducible systems, Ponasterone A triggers stronger gene activation even at lower concentrations. This means more sensitivity in screens and less compound used over the course of a project.
Comparisons in cross-reactivity and toxicity further distinguish Ponasterone A. We’ve collected feedback where 20-hydroxyecdysone occasionally triggered off-target pathways or flagged up solubility concerns. Ponasterone A, especially in our most refined preparations, avoids these pitfalls. Solubility in pro-analytical DMSO reaches high concentrations, essential for labs running high-throughput assays or exploring dose ranges. Shelf-life and storage stability also beat out several other analogs that tend to pick up water or degrade under normal lab conditions.
The trend across the industry shows expanding applications—from developmental biology to targeted gene expression in mammalian and insect cells. With more research pivoting toward tightly regulated inducible gene expression systems, the need for reliable, high-purity Ponasterone A continues to rise. Labs often circle back to us with questions on residual impurities, batch variability, or workable solubility profiles. These are not idle concerns. Academic teams need a compound that delivers predictable response curves; industrial partners ask for repeatable performance in large screening setups.
Our Ponasterone A stands out in these critical parameters. Batch reproducibility, which some call boring, saves weeks of troubleshooting. The minimized impurity profile, validated with both mass spectrometry and NMR, translates into less noise in gene induction data. While the market occasionally gets swept up in cheaper, lower-grade offerings, the feedback reads the same every time: compromised purity comes back to haunt the dataset, not just the ordering department.
Quality control for Ponasterone A goes beyond ticking boxes on a certificate of analysis. Every run undertakes full-resolution HPLC and purity confirmation through both positive and negative ion mass spectrometry. By sticking to these standards, our production eliminates ambiguity about what ends up in each vial. This level of detail grew from real-world batch issues years before: a single off-spec batch can upset months of cloning, transfection, or screening efforts downstream. Our intervention at the earliest stage, whether rerunning a recrystallization or recalibrating an analytical column, prevents these headaches for every end user.
Temperature- and light-stabilized storage represent another lesson from earlier years. At ambient humidity, even tightly sealed vials can pick up moisture, especially if left out during a chaotic lab day. We package all shipments under inert gas and offer recommendations for desiccated storage—simple details but with outsize importance to ensure consistent dosing run after run.
Customers typically work with Ponasterone A in transactivation assays, gene switch systems, and as a model ligand for ecdysone receptors. Protocols draw from our collaboration with academic and biotech research teams. A common preparation involves dissolving the crystalline solid in analytical DMSO, followed by dilution into culture media. The solution remains stable for extended periods as long as exposure to ambient moisture is minimal. Some research teams push the compound to the limits—running extended induction periods and high-frequency dosing. Ponasterone A’s backbone stands up well under these protocols, and the extended stability offers an edge over less robust alternatives.
Feedback in cell-based systems points to a clear advantage: lower background activation in off-target cells and sharper dose-response curves. This aids teams looking to parse small but significant shifts in gene expression. A challenge that sometimes crops up involves solubility at the highest concentrations, especially in serum-rich media. After comparing notes with several longtime biotech partners, we recommend filtering through a PTFE membrane after dilution if any precipitation appears—years of supporting research teams taught us these routine workarounds prevent loss of potency.
Handling Ponasterone A in a production setting drives home lessons about its safety and environmental profile. Unlike heavy metal reagents or volatile organics, Ponasterone A presents a manageable hazard profile. Our operators use gloves and the standard set of PPE. The compound does not volatilize, posing no risk of inhalation exposure under regular handling in powder or solution form. Proper chemical waste streams handle discarded solutions. Much of our in-house training covers spill response—not because Ponasterone A is especially hazardous, but because good habits form the backbone of safe lab environments.
Environmental stewardship starts with responsible upstream sourcing and solvent recovery during production. Years ago, solvent losses and outdated extraction media presented headaches both for our order books and our company’s values. Today, our process incorporates low-waste separation and full compliance with local regulatory frameworks—real changes made not for window dressing but for the long-term health of the work environment and the surrounding community.
The Ponasterone A market sees its share of marketing-driven claims—not all of which stand scrutiny. Reports of enhanced gene induction at micromolar doses sometimes inflate performance beyond results from peer-reviewed studies. Customers seek straightforward, defensible data and real performance, not promotional claims. In every lab visit and customer workshop we host, we show raw data from induction curves, side-by-side with the competitor’s best batches. That willingness to open our notebooks builds lasting trust, not only with regulatory partners but with the project leads who use our products across multiple rounds of research.
Academic collaborations push us to refine and reassess. Postdocs and senior scientists do not hold back feedback; their detailed reports have shaped our purification strategy and prompted new ways to maximize shelf-life. At major conferences, we field questions about stress testing under challenging conditions, such as high-throughput workloads or storage outside cold rooms. We hold nothing back in reporting both strengths and observed failure points—that transparency sets apart our operation from the sea of anonymous suppliers.
Our teams regularly visit collaborating labs and field questions that range from dose calculation to batch-to-batch comparison. A significant part of our business day involves troubleshooting protocols that span from insect hormone assays to complex gene switch designs in mammalian systems. One day’s call may center on dissolved stability in serum-free DMEM; another day draws focus to shipping requirements for overseas customers with tight customs regulations.
We approach every question with the same outlook: if a batch causes an issue, we work the problem back to its source. Instead of cycling through automated replies or holding customers at arm’s length, we pull in synthetic chemists or quality leads to isolate and solve the challenge. This direct line of communication—chemist-to-scientist, not marketer-to-customer—yields strong project outcomes and cements partnerships. We find that these interactions, more than any advertising, make the difference for teams that depend on predictable compounds for grant-driven timelines.
Logistics do not always make the exciting headlines but form the unseen structure keeping projects on track. From in-house inventory systems to real-time monitoring of shipping temperatures, we apply a no-shortcuts attitude. For Ponasterone A, correct packaging and prompt dispatch prevent temperature swings that might lead to individual vials arriving in poor condition. Early missteps taught us where to focus energy—insulating shipments during summer months, tracking transit routes in real-time, and offering guidance on post-delivery handling.
On the user side, long-term storage in desiccators or low-humidity freezers extends usable life—procedures developed after months of shelf-stability testing. The aftereffects of skipping these steps always come back through customer feedback channels: loss of potency, inconsistent dissolving, or visible crystallization. Those experiences feed back into constant revision of every FAQ, instruction sheet, and real-world support we provide.
Ponasterone A use has grown beyond transgenic insect studies. Increasingly, cell biologists borrow its selective receptor-binding properties to activate or silence genes in more advanced systems, driving research in cancer biology, developmental genomics, or metabolic engineering. Teams exploring synthetic biology rely on its higher binding affinity for the ecdysone receptor to ensure tighter switches for gene regulation compared to other ecdysteroids. This brings new scrutiny and prompts regular updates to our product recommendations as workflows evolve. Our involvement in these fast-changing areas keeps us grounded—every real application supplies more lessons than static product brochures ever will.
A point that rises in project discussions: some gene switch systems respond more predictably to Ponasterone A than to muristerone A or 20-hydroxyecdysone because of lower activation of off-target genes. For teams screening hundreds of lines or mapping unknown regulatory regions, this difference translates to increased experimental clarity and fewer false positives. Over the years, the best validation comes not from marketing but from teams reporting successful outcomes and repeatable results over dozens of experiments.
Price pressure never disappears from the conversation—especially in academic labs where budgets ride on grant cycles. Some choose to roll the dice with discount grade alternatives, hoping for equivalent results. Those bets rarely pay off. In practice, labs returning to premium-grade Ponasterone A cite reduced troubleshooting, fewer failed runs, and fewer reorders, offsetting whatever savings the lower price might promise. We’ve heard directly from customers who lost weeks of time chasing unclear activation, only discovering residue impurities or batch variance as the hidden cost. The lesson remains unchanged: quality Ponasterone A brings certainty. Labs counting on reproducibility will continue to value that over illusory bargains.
What the chemical industry often does not broadcast are the ordinary, persistent details that keep product performance consistent. For us, it means tightening every link of production, from the selection of raw materials through to every shipment that leaves our loading dock. It means refining the purification at every chance, adding another check to ensure the absence of related impurities that vex complex research projects. It means talking to project leads and PIs, not hearing from them only when something goes wrong.
Experience on the floor, not only behind a desk, shapes our approach. The evolution of Ponasterone A production stretches more than a decade, folding in advances from selective chemistry to smarter logistics. Instead of headline-grabbing claims or empty assurances, we put forward genuine know-how and an open channel for every user’s feedback. In this way, Ponasterone A becomes not merely a catalog entry but a tested resource for those piecing together the future of gene regulation, screening, or developmental biology. That’s not something anyone can duplicate without a history of answering directly for every shipment, every analysis, and every bottle that enters a new research venture.